Literature DB >> 16556602

Differential regulation of interleukin 5-stimulated signaling pathways by dynamin.

Magdalena M Gorska1, Osman Cen, Qiaoling Liang, Susan J Stafford, Rafeul Alam.   

Abstract

Through the yeast two-hybrid screen we have identified dynamin-2 as a molecule that interacts with the alpha subunit of the interleukin (IL) 5 receptor. Dynamin-2 is a GTPase that is critical for endocytosis. We have shown that dynamin-2 interacts with the IL-5 receptor-associated tyrosine kinases, Lyn and JAK2, in eosinophils. Tyrosine phosphorylation of dynamin is markedly enhanced upon IL-5 stimulation. The inhibition of tyrosine kinases results in complete abolition of ligand-induced receptor endocytosis. Inhibition of dynamin by a dominant-negative mutant or by small interfering RNA results in enhancement of IL-5-stimulated ERK1/2 signaling and cell proliferation. In contrast, the absence of a functional dynamin does not affect STAT5 or AKT phosphorylation or cell survival. Thus, we have identified specific functions for dynamin in the IL-5 signaling pathway and demonstrated its role in receptor endocytosis and termination of the ERK1/2 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556602     DOI: 10.1074/jbc.M512718200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Genome-wide gene and pathway analysis.

Authors:  Li Luo; Gang Peng; Yun Zhu; Hua Dong; Christopher I Amos; Momiao Xiong
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

2.  Novel Biochemical and Structural Insights into the Interaction of Myristoylated Cargo with Unc119 Protein and Their Release by Arl2/3.

Authors:  Mamta Jaiswal; Eyad K Fansa; Stefanie K Kösling; Tom Mejuch; Herbert Waldmann; Alfred Wittinghofer
Journal:  J Biol Chem       Date:  2016-08-01       Impact factor: 5.157

3.  UNC119 is required for G protein trafficking in sensory neurons.

Authors:  Houbin Zhang; Ryan Constantine; Sergey Vorobiev; Yang Chen; Jayaraman Seetharaman; Yuanpeng Janet Huang; Rong Xiao; Gaetano T Montelione; Cecilia D Gerstner; M Wayne Davis; George Inana; Frank G Whitby; Erik M Jorgensen; Christopher P Hill; Liang Tong; Wolfgang Baehr
Journal:  Nat Neurosci       Date:  2011-06-05       Impact factor: 24.884

4.  Src kinase regulates the integrity and function of the Golgi apparatus via activation of dynamin 2.

Authors:  Shaun G Weller; Mirco Capitani; Hong Cao; Massimo Micaroni; Alberto Luini; Michele Sallese; Mark A McNiven
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 5.  Dynamin 2 and human diseases.

Authors:  Anne-Cécile Durieux; Bernard Prudhon; Pascale Guicheney; Marc Bitoun
Journal:  J Mol Med (Berl)       Date:  2010-02-03       Impact factor: 4.599

6.  SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.

Authors:  Timothy M Piazza; Juu-Chin Lu; Kristopher C Carver; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2008-12-04

Review 7.  Uncoordinated (UNC)119: coordinating the trafficking of myristoylated proteins.

Authors:  Ryan Constantine; Houbin Zhang; Cecilia D Gerstner; Jeanne M Frederick; Wolfgang Baehr
Journal:  Vision Res       Date:  2012-09-19       Impact factor: 1.886

8.  Separate endocytic pathways regulate IL-5 receptor internalization and signaling.

Authors:  Jonathan T Lei; Margarita Martinez-Moczygemba
Journal:  J Leukoc Biol       Date:  2008-05-29       Impact factor: 4.962

9.  Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice.

Authors:  Nathan Eaton; Caleb Drew; Jon Wieser; Adam D Munday; Hervé Falet
Journal:  Haematologica       Date:  2019-07-11       Impact factor: 9.941

10.  MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation.

Authors:  Magdalena M Gorska; Qiaoling Liang; Susan J Stafford; Nicolas Goplen; Nilesh Dharajiya; Lei Guo; Sanjiv Sur; Matthias Gaestel; Rafeul Alam
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.